Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis

In Vivo

Volumn 22, Issue 1, 2008, Pages 137-142

  Andreadou, Elisabeth ^a   Kapaki, Elisabeth ^a   Kokotis, Panagiotis ^a   Paraskevas, George P ^a   Katsaros, Nikolaos ^a   Libitaki, Georgia ^a   Petropoulou, Olga ^a   Zis, Vassilios ^a   Sfagos, Constantinos ^a   Vassilopoulos, Demetrios ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Amyotrophic lateral sclerosis; Excitotoxicity; Glutamate; Glycine; Plasma

Indexed keywords

GLUTAMIC ACID; GLYCINE;

ADULT; AGED; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DISEASE DURATION; DISEASE MARKER; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; SEX DIFFERENCE; SPINAL CORD DISEASE; VOLUNTEER;

EID: 40749099400     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Leigh PN and Meldrum BS: Excitotoxicity in ALS. Neurology 47(Suppl 4): 221-227, 1996.
2. Robberecht WL and Vianney De Jong JMB: Oxidative stress in amyotrophic lateral sclerosis: pathogenic mechanism or epiphenomenon? In: Amyotrophic Lateral Sclerosis. Brown B Jr, Meininger V, Swash M (eds.). London, M Dunitz, pp. 211-22, 2000.
3. Beal MF, Hyman BT and Koroshetz W: Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci 16: 125-131, 1993.
4. Young AB, Penney JB, Dauth GW, Bromberg MB and Gilman S: Glutamate or aspartate as a possible neurotransmitter of the central cortico-fugal fibers in the monkey. Neurology 33: 1513-1516, 1983.
5. Rothstein JD, Van Kammen M, Levey AI, Martin LJ and Kuncl RW: Selective loss of glial glutamate transport GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38: 73-84, 1995.
6. Appel SH: Excitotoxic neuronal death in amyotrophic lateral sclerosis. Trends Neurosci 16: 3-5, 1993.
7. Plaitakis A: Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis. Ann Neurol 28: 3-8, 1990.
8. Mayer ML, Vyklicky L JR and Clements J: Regulation of NMDA receptor desensitization in mouse hippocampal neurons by glycine. Nature 338: 425-427, 1989.
9. O'Brien RJ and Fischbach GD: Modulation of embryonic chick motorneuron glutamate sensitivity by interneurons and agonists. J Neurosci 6: 3290-3296, 1986.
10. Plaitakis A and Caroscio JT: Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol 22: 575-579, 1987.
11. Perry TL, Krieger C, Hansen S and Eisen A: Amyotrophic lateral sclerosis: aminoacid levels in plasma and cerebrospinal fluid. Ann Neurol 28: 12-17, 1990.
12. Rothstein JD, Tsai G, Kuncl RW,Clawson L, Cornblath DR, Drachman DB, Penstrnk A, Stauch BL and Coyle JT: Abnormal excitatory aminoacid metabolism in amyotrophic lateral sclerosis. Ann Neurol 28: 18-25, 1990.
13. Iwasaki Y, Ikeda K and Kinoshita M: Plasma aminoacid levels in patients with amyotrophic lateral sclerosis. J Neurol Sci 107: 219-222, 1992.
14. Camu W, Billiard M and Baldy-Moulinier M: Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis. Acta Neurol Scand 88: 51-55, 1993.
15. Niebroj-Dobosz I and Janik P: Amino acids acting as neurotransmitters in amyotrophic lateral sclerosis (ALS). Acta Neurol Scand 100: 6-11, 1999.
16. World Federation of Neurology Research Group on Neuromuscular Disease: The El Escorial Criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 124(Suppl): 96-107, 1994.
17. World Federation of Neurology Research Group on Motor Neuron Disease. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. World Federation of Neurology 1998 (http://www.wfnals.org).
18. Appel V, Stewart SS, Smith G and Appel SH: A rating scale of amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 22: 328-333, 1987.
19. Dagilas A, Kimiskidis V, Aggelopoulou M, Kapaki E, Fitili C, Libitaki G, Papagiannopoulos S, Kazis D; Kazis A and Aidonis A: Changes in blood neurotransmitter and steroid levels during evoked vertigo. Otol Neurootol 26: 476-480, 2005.
20. Paraskevas GP, Triantafyllou NI, Kapaki E, Limpitaki G, Petropoulou O and Vassilopoulos D: Add-on lamotrigine treatment and plasma glutamate levels in epilepsy: relation to treatment response. Epilepsy Res 70: 184-189, 2006.
21. European Research Network for evaluation and improvement of screening, diagnosis and treatment of inherited disorders of metabolism (http://www.erndimqa.nl).
22. Ferrarese C, Pecora N, Frigo M, Appollonio I and Frattola L: Assessment of reliability and biological significance of glutamate levels in cerebrospinal fluid. Ann Neurol 33: 316-319, 1993.
23. Niebroj-Dobosz I, Janik P and Kwiecinski H: Effect of Riluzole on serum aminoacids in patients with amyotrophic lateral sclerosis. Acta Neurol Scand 106: 39-43, 2002.
24. Spreux-Varoquaux O, Bensimon G, Lacomblez L, Salachas F, Pradat PF, Le Forestier N, Marouan A, Dib M and Meininger V: Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J Neurol Sci 193: 73-78, 2002.
25. 3H]CNQX in human motor cortex, brainstem and spinal cord. Brain Res 630: 75-81, 1993.
26. 3H]MK-801 binding sites in the normal human spinal cord. Brain Res 539: 164-168, 1991.
27. Van Westerlaak MGH, Joosten EAJ, Grinau AAM, Cools AR and Bär PR: Differential cortico-motoneuron vulnerability after chronic mitochondrial inhibition in vitro and the role of glutamate receptors. Brain Res 922: 243-249, 2001.
28. McLean MJ: Principles of neuropharmacology and therapeutics. In: Neurology in Clinical Practice, Fourth ed. Bradley WG, Daroff RB, Fenichel GM, Jankovic J (eds.). Philadelphia, Butterworth Heinemann, pp. 881-884, 2004.
29. Eisen A, Schulzer M, MacNeil M, Pant B and Mak E: Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve 16: 27-32, 1993.